Effect of oral zinc supplements on the nutritional status of patients treated with continuous ambulatory peritoneal dialysis;Efecto de suplementos de cinc sobre el estado nutricio de pacientes en diĺisis peritoneal continua ambulatoria

Revista de Investigacion Clinica

Volumn 55, Issue 5, 2003, Pages 519-527

  Munguía, Catarina ^a   Paniagua, Ramón ^b   Ávila Díaz, Marcela ^b   Nava Hernández, Julia ^c   Rodríguez, Ernesto ^b   de Jesús Ventura, María ^b   Amato, Dante ^a,b  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^b HOSPITAL DE ESPECIALIDADES   (Mexico)

^c Hospital General de Zona IMSS   (Mexico)

Author keywords

Continuous ambulatory peritoneal dialysis; End stage renal disease; Nutritional status; Randomized clinical trial; Zinc supplementation

Indexed keywords

ALBUMIN; PREALBUMIN; TRANSFERRIN; ZINC;

ADOLESCENT; ADULT; AGE; ANTHROPOMETRY; ARTICLE; BODY COMPOSITION; CARBOHYDRATE INTAKE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; DRUG ABSORPTION; DRUG CAPSULE; DRUG EFFICACY; DRUG WITHDRAWAL; ENERGY CONSUMPTION; FAT INTAKE; FEMALE; FOLLOW UP; GENDER; HUMAN; IMPEDANCE; KIDNEY FAILURE; MALE; NUTRITIONAL STATUS; PATIENT CODING; PATIENT COMPLIANCE; PROTEIN INTAKE; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; TIME; ZINC BLOOD LEVEL;

ADOLESCENT; ADULT; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; NUTRITIONAL STATUS; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY; ZINC;

EID: 0346266157     PISSN: 00348376     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Amato D, Paniagua R. Prevalencia de insuficiencia renal crónica en la población derechohabiente del Instituto Mexicano del Seguro Social. En: García Peña MC, Reyes Morales H, Viniegra Velásquez L. Las múltiples facetas de la investigación en salud. México, D.F: Sestante, S. A. de C. V.; 2001, p. 153-70.
2. Su-Hernández L, Abascal-Macias A, Méndez-Bueno FJ, Paniagua R, Amato D. Epidemiologic and demographic aspects of peritoneal dialysis in Mexico. Perit Dial Int 1996; 16: 362-5.
3. Beyersmann D, Haase H. Functions of zinc in signaling, proliferation and differentiation of mammalian cells. Biometals 2001; 14: 331-41.
4. McNall AD, Etherton TD, Fosmire G.J. The impaired growth induced by zinc deficiency in rats is associated with decreased expression of the hepatic insulin-like growth factor I and growth hormone receptor genes. J Nutr 1995; 125: 874-9.
5. Nakamura T, Nishiyama S, Futagoishi-Suginohara Y, Matsuda I, Higashi A. Mild to moderate zinc deficiency in short children: effect of zinc supplementation on lineal growth velocity. J Pediatr 1993; 123: 65-9.
6. Ulmer DD. Trace elements. New Engl J Med 1997; 297: 318-21.
7. López-Uriarte A, Ramos-Contreras P, Díaz-Bensussen S, López-Montaño E, Vargas-Rosendo R. Zinc in plasma and red blood cells of children with chronic renal failure. Arch Invest Med 1984; 15: 45-54.
8. Paniagua R, Pérez A, Díaz S, Solís L, Saavedra H, Exaire E. Zinc and cooper concentration in plasma and erythrocytes of patients with chronic renal failure. Arch Invest Med 1981; 12: 69-82.
9. Mahajan SK. Zinc metabolism in uremia. Int J Artificial Organs 1988; 11: 223-8.
10. Jern NA, Van Beber AD, Gorman MA, Weber CG, Liepa GU, Cochran CC. The effect of zinc supplementation on serum Zinc concentration and protein catabolic rate in hemodialysis patients. J Ren Nutr 2000; 10: 148-453.
11. Holtkamp W, Brodersen HP, Stollberg T, Thiery J, Falkner C. Zinc supplementation stimulates tetanus antibody formation and soluble interleukin-2 receptor levels in chronic hemodialysis patients. Clin Invest 1993; 71: 537-41.
12. Travaglini P, Moriondo P, Togni E, Benegoni P, Bochicchio D, Conti A, Ambroso G, Ponticelli C, Mocchegiani E, Fabris N. Effect of oral zinc administration on prolactin and thymulin circulating levels in patients with chronic renal failure. J Clin Endocrinol Metab 1989; 68: 186-90.
13. Grekas D, Alivanis P, Kotzadamis N, Kiriazopoulou V, Pyrpasopoulos M, Tourkantonis A. Influenza vaccination in chronic hemodialysis patients. The effect of Zinc supplementation. Ren Fail 1992; 14: 575-8.
14. Paniagua R, Claure R, Amato D, Flores E, Pérez A, Exaire E. Effects of oral administration of zinc and diiodohydroxyquinolein on plasma zinc levels of uremic patients. Nephron 1995; 69: 147-50.
15. Mahajan SK, Abbasi AA, Prasad AS, Rabbani P, Briggs WA, McDonald FD. Effect of oral Zinc therapy on gonadal function in hemodialysis patients. A double blind study. Ann Intern Med 1982; 97(357): 35-61.
16. Brook AC, Johnston DG, Ward MK, Watson MJ, Cook DB, Kerr DN. Absence of a therapeutic effect of Zinc in the sexual dysfunction of haemodialysed patients. Lancet 1980; 2(8,195 pt 1): 618-20.
17. Arreola F, Paniagua R, Pérez A, Díaz S, Junco E, Villalpando S, Exaire E. Effect of Zinc treatment on serum thyroid hormones in uremic patients under peritoneal dialysis. Horm Metab Res 1993; 25: 539-42.
18. Grekas D, Tsakalos N, Giannopoulos Z, Tourkantonis A. Effect of zinc treatment on cell mediated immunity of chronic renal failure patients. Proc Eur Dial Transplant Assoc Eur Ren Assoc 1985; 21: 825-9.
19. Eggert JV, Siegler RL, Edomkesmalee E. Zinc supplementation in chronic renal failure. Int J Pediatr Nephrol 1982; 3: 21-4.
20. Mahajan SK, Prasad AS, Lambujon J, Abbasi AA, Briggs WA, McDonald ED. Improvement of uremic hypogeusia by Zinc: A double-blind study. Am J Clin Nutr 1980; 33: 1517-21.
21. Watson AR, Stuart A, Wells FE, Houston IB, Addison GM. Zinc supplementation and its effect on taste acuity in children with chronic renal failure. Hum Nutr Clin Nutr 1983; 37: 219-25.
22. Espinosa A, Cueto-Manzano AM, Velásquez-Alva C, Hernández A, Cruz N. Zamora B, Chaparro A, Irigoyen E, Correa-Rotter R. Prevalence of malnutrition in Mexican CAPD diabetic and nondiabetic patients. Adv Perit Dial 1996; 12: 302-6.
23. Foulks JC. An evidence-based evaluation of intradialytic parenteral nutrition. Am J Kidney Dis 1999; 33: 186-92.
24. Kopple JD, Bernard D, Messana J, Swartz R, Bergstrom J, Lindholm B, Lim V, Brunori G, Leiserowitz M, Bier DM. Treatment of malnourished CAPD patients with an amino acid based dialysate. Kidney Int 1995; 47: 1148-57.
25. Ikizler TA, Wingard LR, Breyer AJ, Schulman G, Parker AR, Hakim MR. Short-term effects of recombinant human growth hormone in CAPD patients. Kidney Int 1994; 46: 1178-83.
26. Fouque D, Peng SC, Kopple JD. Impaired metabolic response to recombinant insulin-like growth factor-1 in dialysis patients. Kidney Int 1995; 47: 876-83.
27. Paniagua R, Arreola F, Herrera J, Pérez A, Díaz S, Mondragón L, Sereno O, Villalpando S, Exaire E, Bermúdez JA. Zinc, prolactin, gonadotropins, and androgen levels in uremic men. Arch Androl 1982; 8: 271-5.
28. Bermúdez JA, Paniagua R, Arreola F, Herrera J, Pérez A, Díaz S, Mondragón L, Gómez-Orta F, Villalpando S, Exaire E. Endocrine profile in patients with chronic renal failure under Zinc replacement. Arch Androl 1982; 9: 167-9.
29. National Kidney Foundation. Kidney Disease Outcomes Quality Initiative. Clinical practice guidelines for nutrition in chronic renal failure. Appendix VI. Methods for performing subjective global assessment. Am J Kidney Dis 2000; 36 [Suppl. 2]: S75.
30. Chertow GM, Lazarus JM, Lew NL, Ma L, Lowrie EG. Bioimpedance norms for the hemodialysis Population. Kidney Int 1997; 52: 1617-21.
31. Ledezma A. NutriPac. Software para nutriólogos. Versión 1.5, MS-DOS/XP. 1992-2002.
32. Muñoz de Chávez M, Chávez Villasana A, Roldán Amaro JA, Ledesma Solano JA, Mendoza Martínez E, Pérez-Gil Romo F, Hernández Cordero SL, Chaparro Flores AG. Tablas de valor nutritivo de los alimentos de mayor consumo en México. México, D. F.: Editorial Pax México, S. A.; 1996.
33. Fernstrom A, Hylander B, Rossner S. Taste acuity in patients with chronic renal failure. Clin Nephrol 1996; 45: 169-74.
34. National Kidney Foundation. Kidney Disease Outcomes Quality Initiative. Clinical practice guidelines for nutrition in chronic renal failure. I. Adult guidelines. A. Maintenance dialysis. 1. Evaluation of protein-energy nutritional status. Am J Kidney Dis 2000; 36[Suppl. 2]: S17-S37.
35. González EC, Rivas L, Correa-Rotter R, Espinosa MA. Aplicación del método de vectores de impeclancia para la composición corporal y el estado de hidratación en pacientes con diálisis (Resumen). Memorias, L1 Reunión Anual, Instituto Mexicano de Investigaciones Nefrológicas. Acapulco, México; 2002, p 5.
36. Gamba G, Mejia JL, Saldívar S, Peña JC, Correa-Rotter R. Death risk in CAPD patients. Nephron 1993; 65: 558-62.
37. Lowrie GE, Lew NL. Death risk in hemodialysis patients: the predictive value of commonly measured variables and evaluation of death rate differences between facilities. Am J Kidney Dis 1990; 15: 458-82.
38. Chertow GM, Ackert K, Lew NL, Lazarus JM, Lowrie EG. Prealbumin is as important as albumin in the nutritional assessment of hemodialysis patients. Kidney Int 2000; 58: 5212-7.
39. Cueto-Manzano AM. Hipoalbuiminemia en diálisis. ¿Es un marcador de desnutrición o inflamación? Rev Invest Clin 2001; 53: 152-8.
40. Jones CH, Wells L, Stoves J, Farquhar F, Woodrow G. Can a reduction in extracellular fluid volume result in increased serum albumin in peritoneal dialysis patients? Am J Kidney Dis 2002; 39: 872-5.
41. Holley JL, Aslam N, Bernardini J, Fried L, Piraino B. The influence of demographic factors and modality on loss of residual renal function in incident peritoneal dialysis patients. Perit Dial Int 2001; 21: 302-5.
42. Fussholler A, zur Nieden S, Grabensee B, Plum J. Peritoneal fluid and solute transport: Influence of' treatment time, peritoneal dialysis modality, and peritonitis incidence. J Am Soc Nephrol 2002; 13: 1055-60.
43. Krediet RT, Van Esch S, Smit W, Michels WM, Zweers MM, Ho-Dac-Pannekeet MM, Struijk DG. Peritoneal membrane failure in peritoneal dialysis patients. Blood Purif 2002; 20: 489-93.